100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
Gamithromycin Isomer Impurity
● Under Development
| Catalogue No.: | VE0010082 |
|---|---|
| CAS No.: | N/A |
| Mol. Formula: | C40H76N2O12 |
| Mol. Weight: | 777.04 g/mol |
Additional information on Gamithromycin Isomer Impurity
Parent drug
GamithromycinIUPAC Name
Gamithromycin Isomer impuritySynonyms
(3R,6R,8R,9R,10S,11S,12R)-2-((2R,3S)-2,3-dihydroxypentan-2-yl)-9-(((2S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-hydroxy-11-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,6,8,10,12-pentamethyl-5-propyl-1-oxa-5-azacyclotridecan-13-one;Description
It is one of impurity present in Gamithromycin, Gamithromycin is approved for the treatment and prevention of bovine respiratory disease, which is caused mainly by Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma species. Gamithromycin is an antibiotic used in cattle.References
Yang, Q., Liu, X., Zhang, C., Yong, K., Clifton, A. C., Ding, H., & Liu, Y. (2019). Pharmacokinetics and Pharmacodynamics of Gamithromycin Treatment of Pasteurella multocida in a Murine Lung Infection Model. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.01090Request a Quote
"*" indicates required fields
Other products related to Gamithromycin impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
